ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,166Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 783

$896K Total Retail Price of All Prescriptions

Rank: 67 out of 783

649 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 649 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 649 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 10,846 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,303 871 S3 1 2
AMLODIPINE BESYLATE 477 446 2 5
PRAVASTATIN SODIUM 420 341 3 14
SIMVASTATIN 385 311 4 3
ZOLPIDEM TARTRATE 380 286 5 23
OMEPRAZOLE 377 241 6 6
METOPROLOL SUCCINATE 369 325 7 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 291 229 8 33
LEVOTHYROXINE SODIUM 281 233 9 1
ATENOLOL 275 223 10 17
LISINOPRIL 215 166 11 4
SERTRALINE HCL 207 149 12 22
GABAPENTIN 193 119 13 15
TAMSULOSIN HCL 185 140 14 26
CEPHALEXIN 182 133 15 70
CITALOPRAM HBR 180 145 16 19
LOSARTAN-HYDROCHLOROTHIAZIDE 177 160 17 53
METFORMIN HCL 155 118 18 8
ATORVASTATIN CALCIUM 153 121 19 11
CRESTOR 153 103 19 27
PROMETHAZINE HCL 144 100 R 21 97
WARFARIN SODIUM 140 132 22 10
FUROSEMIDE 138 106 23 7
OXYCODONE HCL-ACETAMINOPHEN 130 68 S2 24 86
NEXIUM 129 81 25 28
ISOSORBIDE MONONITRATE ER 128 111 26 40
TRAMADOL HCL 128 83 26 20
LANTUS 122 68 28 38
ALPRAZOLAM 122 46 28 145
HYDROCHLOROTHIAZIDE 120 107 30 12
METOPROLOL TARTRATE 118 95 31 9
CELEBREX 117 91 32 93
FLUTICASONE PROPIONATE 117 70 32 46
DONEPEZIL HCL 116 113 34 24
ALENDRONATE SODIUM 114 113 35 25
BACLOFEN 114 76 35 125
METHADONE HCL 103 27 S2 37 193
CYCLOBENZAPRINE HCL 102 64 R 38 63
PREDNISONE 101 72 39 36
RANITIDINE HCL 97 43 40 44
PAROXETINE HCL 93 61 41 69
POTASSIUM CHLORIDE 93 74 41 16
NAMENDA 90 90 43 32
DIOVAN HCT 89 82 44 94
CLOPIDOGREL 88 79 45 29
CLONIDINE HCL 87 63 46 60
AZITHROMYCIN 85 60 47 41
ALLOPURINOL 78 59 48 31
CYMBALTA 77 39 49 35
PROAIR HFA 77 46 49 56
GLIMEPIRIDE 76 56 51 34
ADVAIR DISKUS 76 48 51 50
MELOXICAM 76 71 51 37
PANTOPRAZOLE SODIUM 76 51 51 30
BUPROPION HCL SR 75 28 55 166
SPIRIVA 75 75 55 59
TRIAMCINOLONE ACETONIDE 74 55 57 151
ESCITALOPRAM OXALATE 73 55 58 54
DIGOXIN 72 72 59 61
PLAVIX 71 64 60 51
CIPROFLOXACIN HCL 69 42 61 62
SYMBICORT 68 39 62 157
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 49 62 154
QUETIAPINE FUMARATE 68 38 62 79
INSULIN SYRINGE 67 24 65 82
SINGULAIR 66 25 66 90
VENLAFAXINE HCL ER 66 38 66 100
AMLODIPINE BESYLATE-BENAZEPRIL 65 43 68 83
MORPHINE SULFATE ER 62 37 S2 69 107
HYDRALAZINE HCL 61 53 70 78
DIPHENOXYLATE-ATROPINE 57 41 71 266
METHOTREXATE 54 16 72 158
CARVEDILOL 53 44 73 21
DILTIAZEM 24HR CD 53 42 73 118
NITROFURANTOIN MONO-MACRO 53 34 73 174
TOPIRAMATE 52 24 76 152
ESTRADIOL 52 22 R 76 204
LOSARTAN POTASSIUM 52 44 76 18
BUMETANIDE 51 41 79 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.